Word

Status

Pending

Status Code

694

Status Date

Friday, April 26, 2024

Serial Number

97811501

Mark Type

5

Filing Date

Friday, February 24, 2023

Trademark Owner History

3D Medicines (Beijing) Co., Ltd. - Owner At Publication

Classifications

5 Pharmaceutical products for the prevention and treatment of cancer; Medicinal preparations for the prevention and treatment of tumors; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Antiviral drugs for medical purposes; Crude drugs in the nature of pharmaceutical preparations for the treatment of immune system related diseases and disorders; Gelatin capsules sold empty for pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for tumors; Injectable pharmaceuticals for treatment of cancer; Biological preparations for the treatment of cancer

The mark consists of the stylized wording "Enrilong".

Trademark Events

Feb 28, 2023

New Application Entered

Mar 16, 2023

New Application Office Supplied Data Entered

Nov 24, 2023

Assigned To Examiner

Nov 25, 2023

Non-Final Action Written

Nov 25, 2023

Non-Final Action E-Mailed

Nov 25, 2023

Notification Of Non-Final Action E-Mailed

Jan 8, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jan 8, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Jan 8, 2024

Teas Change Of Correspondence Received

Jan 8, 2024

Teas Withdrawal Of Attorney Received-Firm Retains

Jan 10, 2024

Teas Response To Office Action Received

Jan 10, 2024

Correspondence Received In Law Office

Jan 11, 2024

Teas/Email Correspondence Entered

Jan 15, 2024

Approved For Pub - Principal Register

Jan 19, 2024

On Hold - Electronic Record Review Required

Feb 1, 2024

Electronic Record Review Complete

Feb 21, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 21, 2024

Notification Of Notice Of Publication E-Mailed

Mar 12, 2024

Published For Opposition

Mar 12, 2024

Official Gazette Publication Confirmation E-Mailed

Apr 26, 2024

Withdrawn From Issue - Comm.Office Request